Quarterly report pursuant to Section 13 or 15(d)

Segment Disclosures - Operating Segments (Details)

v3.21.2
Segment Disclosures - Operating Segments (Details)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2021
USD ($)
segment
Sep. 30, 2020
USD ($)
Segment Reporting Information [Line Items]        
Number of reportable segments | segment     2  
Revenue $ 3,049 $ 2,897 $ 7,170 $ 6,628
Cost of revenue 1,242 1,084 2,836 2,919
Gross profit 1,807 1,813 4,334 3,709
EksoHealth        
Segment Reporting Information [Line Items]        
Revenue 2,716 2,739 6,306 6,015
Cost of revenue 1,044 989 2,326 2,466
Gross profit 1,672 1,750 3,980 3,549
EksoWorks        
Segment Reporting Information [Line Items]        
Revenue 333 158 864 613
Cost of revenue 198 95 510 453
Gross profit $ 135 $ 63 $ 354 $ 160